Casey M. Stern
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Casey M. Stern has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Jennifer Joanne Thomas
Eating Disorders Clinical and Research Program Massachusetts General Hospital Boston Massachusetts USA
10 shared publications - Kendra R. Becker
Eating Disorders Clinical and Research Program Massachusetts General Hospital Boston Massachusetts USA
10 shared publications - Kamryn T. Eddy
Eating Disorders Clinical and Research Program Massachusetts General Hospital Boston Massachusetts USA
9 shared publications - Lauren Breithaupt
Massachusetts General Hospital
9 shared publications - Helen Burton Murray
Center for Neurointestinal Health, Division of Gastroenterology Massachusetts General Hospital Boston Massachusetts USA
7 shared publications - Elizabeth Austen Lawson
Mass General Brigham Eating Disorders Research Collaborative Boston Massachusetts USA
6 shared publications
Latest Publications
- 17 August 2026
- Published by Wiley in International Journal of Eating Disorders
Eating Disorder Diagnostic Crossover: A Meta‐Analysis
Objective: Diagnostic crossover among eating disorders (EDs) is clinically important, yet rates are inconsistently quantified. This meta‐analysis aims to quantify the frequency and direction of diagnostic crossover among EDs (both within‐syndrome and between‐syndrome), to evaluate study‐level moderators of crossover rates, and to conduct a formal appraisal of the quality of the included studies. Method: A literature search was conducted following PRISMA 2020 guidelines, including all relevant articles on PsycINFO, Pubmed/Medline, and ProQuest Dissertations & Theses Global databases from inception to June 10, 2026. Twenty‐seven studies (24 samples; 287 effect sizes) were synthesized using random‐effects models. Mixed‐effects models tested diagnostic criteria, follow‐up duration, treatment setting, diagnostic method, and demographics as moderators. Results: Between‐syndrome crossovers (e.g., bulimia nervosa [BN] to anorexia nervosa [AN]) were rare, ranging from 0% (e.g., AN to binge eating disorder [BED]) to 13% (e.g., BED to BN), whereas within‐syndrome shifts such as AN subtype shifts (23% from restrictive to binge‐purging type) and transitions into other specified feeding or eating disorder (OSFED)/eating disorder not otherwise specified (EDNOS) were more common (17% to 25% across syndromes). Diagnostic criteria and method were significant moderators. Discussion: Diagnostic instability reflects within‐AN shifts and OSFED/EDNOS transitions more than between‐syndrome crossovers, underscoring the value of repeated specialist, interview‐based reassessment.
- 17 August 2026
- Published by Wiley in International Journal of Eating Disorders
Eating Disorder Diagnostic Crossover: A Meta‐Analysis
Objective: Diagnostic crossover among eating disorders (EDs) is clinically important, yet rates are inconsistently quantified. This meta‐analysis aims to quantify the frequency and direction of diagnostic crossover among EDs (both within‐syndrome and between‐syndrome), to evaluate study‐level moderators of crossover rates, and to conduct a formal appraisal of the quality of the included studies. Method: A literature search was conducted following PRISMA 2020 guidelines, including all relevant articles on PsycINFO, Pubmed/Medline, and ProQuest Dissertations & Theses Global databases from inception to June 10, 2026. Twenty‐seven studies (24 samples; 287 effect sizes) were synthesized using random‐effects models. Mixed‐effects models tested diagnostic criteria, follow‐up duration, treatment setting, diagnostic method, and demographics as moderators. Results: Between‐syndrome crossovers (e.g., bulimia nervosa [BN] to anorexia nervosa [AN]) were rare, ranging from 0% (e.g., AN to binge eating disorder [BED]) to 13% (e.g., BED to BN), whereas within‐syndrome shifts such as AN subtype shifts (23% from restrictive to binge‐purging type) and transitions into other specified feeding or eating disorder (OSFED)/eating disorder not otherwise specified (EDNOS) were more common (17% to 25% across syndromes). Diagnostic criteria and method were significant moderators. Discussion: Diagnostic instability reflects within‐AN shifts and OSFED/EDNOS transitions more than between‐syndrome crossovers, underscoring the value of repeated specialist, interview‐based reassessment.
- Open Access
- 17 April 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e91761
Combining Digital Cognitive Behavioral Therapy With Mindfulness Training for Binge Eating Disorder: Protocol for a Feasibility Trial
Background: Cognitive behavioral therapy (CBT) is the most effective treatment for binge eating disorder (BED) but is limited by modest efficacy and low reach of in-person delivery. Combining mindfulness training with CBT could enhance efficacy by targeting emotion dysregulation, a key factor in BED that CBT does not adequately target. Digital delivery can enhance the reach of treatment. Accordingly, we developed CBT-based Mindful Courage, a 16-session digital intervention combining CBT and mindfulness training for BED. Objective: The aim of this study is to conduct a pilot randomized controlled trial to evaluate the feasibility (intervention and assessment completion) and acceptability (usability, overall satisfaction, engagement, visual appeal of content, understandability of program content, desire to continue the program, perceived skill acquisition, perceived confidence in implementing skills, and perceived helpfulness) of CBT-based Mindful Courage. We will also evaluate changes in outcomes (binge eating frequency, eating disorder symptoms, clinical impairment, and depression symptoms) and mechanisms (emotion dysregulation, dietary overrestriction, and trait mindfulness). Methods: This is a parallel-group, single-blinded, randomized controlled trial with a 1:1 allocation ratio. It will be conducted from November 2025 to November 2026, with study assessments at baseline, midtreatment, end-of-treatment, and 2-month follow-up. We will recruit a volunteer sample of adults with BED (N=40) aged 18 to 75 years via online advertisements. Exclusion criteria include a BMI <18.5, current anorexia or bulimia nervosa, and current treatment for BED or weight loss. Participants will be randomly allocated to an active control that includes coached self-monitoring (self-monitoring of food intake in Recovery Record and coaching calls by a research assistant) or to CBT-based Mindful Courage+coached self-monitoring. Both conditions will have a duration of 18 weeks. All study sessions will take place over Zoom. Results: The study was funded in April 2023. Data collection began in November 2025, and we anticipate recruitment to be completed by November 2026. Results are expected to be analyzed by May 2027 and published by May 2028. Conclusions: This will be an important first step in creating a scalable and efficacious treatment for BED. Trial Registration: ClinicalTrials.gov NCT07212673; https://clinicaltrials.gov/study/NCT07212673 International Registered Report Identifier (IRRID): DERR1-10.2196/91761
- 17 April 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e91761
Open AccessCombining Digital Cognitive Behavioral Therapy With Mindfulness Training for Binge Eating Disorder: Protocol for a Feasibility Trial
Background: Cognitive behavioral therapy (CBT) is the most effective treatment for binge eating disorder (BED) but is limited by modest efficacy and low reach of in-person delivery. Combining mindfulness training with CBT could enhance efficacy by targeting emotion dysregulation, a key factor in BED that CBT does not adequately target. Digital delivery can enhance the reach of treatment. Accordingly, we developed CBT-based Mindful Courage, a 16-session digital intervention combining CBT and mindfulness training for BED. Objective: The aim of this study is to conduct a pilot randomized controlled trial to evaluate the feasibility (intervention and assessment completion) and acceptability (usability, overall satisfaction, engagement, visual appeal of content, understandability of program content, desire to continue the program, perceived skill acquisition, perceived confidence in implementing skills, and perceived helpfulness) of CBT-based Mindful Courage. We will also evaluate changes in outcomes (binge eating frequency, eating disorder symptoms, clinical impairment, and depression symptoms) and mechanisms (emotion dysregulation, dietary overrestriction, and trait mindfulness). Methods: This is a parallel-group, single-blinded, randomized controlled trial with a 1:1 allocation ratio. It will be conducted from November 2025 to November 2026, with study assessments at baseline, midtreatment, end-of-treatment, and 2-month follow-up. We will recruit a volunteer sample of adults with BED (N=40) aged 18 to 75 years via online advertisements. Exclusion criteria include a BMI <18.5, current anorexia or bulimia nervosa, and current treatment for BED or weight loss. Participants will be randomly allocated to an active control that includes coached self-monitoring (self-monitoring of food intake in Recovery Record and coaching calls by a research assistant) or to CBT-based Mindful Courage+coached self-monitoring. Both conditions will have a duration of 18 weeks. All study sessions will take place over Zoom. Results: The study was funded in April 2023. Data collection began in November 2025, and we anticipate recruitment to be completed by November 2026. Results are expected to be analyzed by May 2027 and published by May 2028. Conclusions: This will be an important first step in creating a scalable and efficacious treatment for BED. Trial Registration: ClinicalTrials.gov NCT07212673; https://clinicaltrials.gov/study/NCT07212673 International Registered Report Identifier (IRRID): DERR1-10.2196/91761
- 9 March 2026
- Published by Wiley in International Journal of Eating Disorders
An Exploratory Study of Neural Response to Food Cues Following Cognitive‐Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder
Objective: Avoidant/restrictive food intake disorder (ARFID) is characterized by limited dietary volume and/or variety due to fear of aversive consequences, lack of interest in eating, and/or sensory sensitivity. Uncontrolled studies suggest that cognitive‐behavioral therapy for ARFID (CBT‐AR) is beneficial, but neural mechanisms remain unknown. Prior work has shown hyperactivation in regions of the salience network (SN) during the presentation of food stimuli in ARFID compared to healthy controls, and the SN shows reduction from pre‐ to post‐CBT in anxiety disorders. We tested hypotheses that (1) higher pre‐treatment food‐related activation in the SN (anterior cingulate cortex [ACC], anterior insula, amygdala) would be prospectively associated with greater reductions in ARFID severity at post‐treatment, and (2) food‐related activation in the SN would decrease from pre‐ to post‐treatment. Method: In a validated functional magnetic resonance imaging (fMRI) food cue paradigm, youth with ARFID viewed images of food and non‐food in a fasted state at pre‐treatment ( N = 24) and a subset ( N = 14) also completed post‐treatment scans. Results: Pre‐treatment activation in response to food versus objects was not associated with changes in ARFID severity or remission post‐treatment. However, hyperactivation in the right ACC (MNI coordinates: 3, 53, 17; k ( E ) = 579, p (FWE corr ) = 0.013) decreased from pre‐ to post‐treatment with a large effect size ( d = 1.1). Conclusion: These pilot findings raise the possibility that changes in SN neural activity may be candidate mechanisms through which CBT‐AR exerts its effects. Randomized controlled trials are needed to replicate and extend these results. Trial Registration: ClinicalTrials.gov identifier: NCT02963220
- 9 March 2026
- Published by Wiley in International Journal of Eating Disorders
An Exploratory Study of Neural Response to Food Cues Following Cognitive‐Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder
Objective: Avoidant/restrictive food intake disorder (ARFID) is characterized by limited dietary volume and/or variety due to fear of aversive consequences, lack of interest in eating, and/or sensory sensitivity. Uncontrolled studies suggest that cognitive‐behavioral therapy for ARFID (CBT‐AR) is beneficial, but neural mechanisms remain unknown. Prior work has shown hyperactivation in regions of the salience network (SN) during the presentation of food stimuli in ARFID compared to healthy controls, and the SN shows reduction from pre‐ to post‐CBT in anxiety disorders. We tested hypotheses that (1) higher pre‐treatment food‐related activation in the SN (anterior cingulate cortex [ACC], anterior insula, amygdala) would be prospectively associated with greater reductions in ARFID severity at post‐treatment, and (2) food‐related activation in the SN would decrease from pre‐ to post‐treatment. Method: In a validated functional magnetic resonance imaging (fMRI) food cue paradigm, youth with ARFID viewed images of food and non‐food in a fasted state at pre‐treatment ( N = 24) and a subset ( N = 14) also completed post‐treatment scans. Results: Pre‐treatment activation in response to food versus objects was not associated with changes in ARFID severity or remission post‐treatment. However, hyperactivation in the right ACC (MNI coordinates: 3, 53, 17; k ( E ) = 579, p (FWE corr ) = 0.013) decreased from pre‐ to post‐treatment with a large effect size ( d = 1.1). Conclusion: These pilot findings raise the possibility that changes in SN neural activity may be candidate mechanisms through which CBT‐AR exerts its effects. Randomized controlled trials are needed to replicate and extend these results. Trial Registration: ClinicalTrials.gov identifier: NCT02963220
- 22 January 2026
- Published by Wiley in International Journal of Eating Disorders
- Vol. 59 (5) , 896-910
Acceptability and Feasibility of a Digital Mindfulness‐Based Intervention for Anorexia Nervosa and Bulimia Nervosa
Objective: There is a great need for the development of scalable augmentations to treatments for anorexia nervosa (AN) and bulimia nervosa (BN), as most individuals with AN/BN are currently not able to access treatment. Mindfulness‐based interventions (MBIs) may be promising for AN/BN and lend themselves well to digital delivery, increasing access. We aimed to develop and test the initial acceptability and feasibility of Mindful Courage, a digital MBI for AN/BN and atypical AN/BN. Method: We evaluated an 8‐week version of Mindful Courage including 32 modules (8 core multi‐media lessons, 24 brief audio‐guided mindfulness practices) in N = 32 participants, who also received weekly phone coaching conducted by psychology students. Ten participants (31.2%) were enrolled in outpatient ED treatment while receiving the intervention. Participants completed assessments at baseline, post‐intervention (8 weeks), and 2‐month post‐intervention follow‐up. Results: Acceptability was demonstrated by relatively high ratings for perceived usability (81.34/100), understandability (4.6/5.0), engageability (4.1/5.0), visual appeal (4.1/5.0), helpfulness (4.2/5.0), skills acquisition (4.3/5.0), and confidence applying skills (4.2/5.0). Feasibility was demonstrated by high module completion (an average of 28/32 modules). There were significant reductions in target outcomes: ED symptoms ( d = 1.21), body dissatisfaction ( d = 0.73), depression ( d = 0.76), anxiety ( d = 0.62), and clinical impairment ( d = 1.15). In addition, there were significant improvements in target mechanisms: mindfulness ( d = 0.79), emotion regulation difficulties (d = 0.65 ), and savoring beliefs ( d = 0.58). Discussion: Mindful Courage is a viable and potentially effective intervention. A future randomized‐controlled trial is warranted.
- 22 January 2026
- Published by Wiley in International Journal of Eating Disorders
- Vol. 59 (5) , 896-910
Acceptability and Feasibility of a Digital Mindfulness‐Based Intervention for Anorexia Nervosa and Bulimia Nervosa
Objective: There is a great need for the development of scalable augmentations to treatments for anorexia nervosa (AN) and bulimia nervosa (BN), as most individuals with AN/BN are currently not able to access treatment. Mindfulness‐based interventions (MBIs) may be promising for AN/BN and lend themselves well to digital delivery, increasing access. We aimed to develop and test the initial acceptability and feasibility of Mindful Courage, a digital MBI for AN/BN and atypical AN/BN. Method: We evaluated an 8‐week version of Mindful Courage including 32 modules (8 core multi‐media lessons, 24 brief audio‐guided mindfulness practices) in N = 32 participants, who also received weekly phone coaching conducted by psychology students. Ten participants (31.2%) were enrolled in outpatient ED treatment while receiving the intervention. Participants completed assessments at baseline, post‐intervention (8 weeks), and 2‐month post‐intervention follow‐up. Results: Acceptability was demonstrated by relatively high ratings for perceived usability (81.34/100), understandability (4.6/5.0), engageability (4.1/5.0), visual appeal (4.1/5.0), helpfulness (4.2/5.0), skills acquisition (4.3/5.0), and confidence applying skills (4.2/5.0). Feasibility was demonstrated by high module completion (an average of 28/32 modules). There were significant reductions in target outcomes: ED symptoms ( d = 1.21), body dissatisfaction ( d = 0.73), depression ( d = 0.76), anxiety ( d = 0.62), and clinical impairment ( d = 1.15). In addition, there were significant improvements in target mechanisms: mindfulness ( d = 0.79), emotion regulation difficulties (d = 0.65 ), and savoring beliefs ( d = 0.58). Discussion: Mindful Courage is a viable and potentially effective intervention. A future randomized‐controlled trial is warranted.
- Open Access
- 19 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Combining Digital Cognitive Behavioral Therapy With Mindfulness Training for Binge Eating Disorder: Protocol for a Feasibility Trial (Preprint)
BACKGROUND Cognitive behavioral therapy (CBT) is the most effective treatment for binge eating disorder (BED) but is limited by modest efficacy and low reach of in-person delivery. Combining mindfulness training with CBT could enhance efficacy by targeting emotion dysregulation, a key factor in BED that CBT does not adequately target. Digital delivery can enhance the reach of treatment. Accordingly, we developed CBT-based Mindful Courage, a 16-session digital intervention combining CBT and mindfulness training for BED. OBJECTIVE The aim of this study is to conduct a pilot randomized controlled trial to evaluate the feasibility (intervention and assessment completion) and acceptability (usability, overall satisfaction, engagement, visual appeal of content, understandability of program content, desire to continue the program, perceived skill acquisition, perceived confidence in implementing skills, and perceived helpfulness) of CBT-based Mindful Courage. We will also evaluate changes in outcomes (binge eating frequency, eating disorder symptoms, clinical impairment, and depression symptoms) and mechanisms (emotion dysregulation, dietary overrestriction, and trait mindfulness). METHODS This is a parallel-group, single-blinded, randomized controlled trial with a 1:1 allocation ratio. It will be conducted from November 2025 to November 2026, with study assessments at baseline, midtreatment, end-of-treatment, and 2-month follow-up. We will recruit a volunteer sample of adults with BED (N=40) aged 18 to 75 years via online advertisements. Exclusion criteria include a BMI <18.5, current anorexia or bulimia nervosa, and current treatment for BED or weight loss. Participants will be randomly allocated to an active control that includes coached self-monitoring (self-monitoring of food intake in Recovery Record and coaching calls by a research assistant) or to CBT-based Mindful Courage+coached self-monitoring. Both conditions will have a duration of 18 weeks. All study sessions will take place over Zoom. RESULTS The study was funded in April 2023. Data collection began in November 2025, and we anticipate recruitment to be completed by November 2026. Results are expected to be analyzed by May 2027 and published by May 2028. CONCLUSIONS This will be an important first step in creating a scalable and efficacious treatment for BED. CLINICALTRIAL ClinicalTrials.gov NCT07212673; https://clinicaltrials.gov/study/NCT07212673 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/91761
- 19 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessCombining Digital Cognitive Behavioral Therapy With Mindfulness Training for Binge Eating Disorder: Protocol for a Feasibility Trial (Preprint)
BACKGROUND Cognitive behavioral therapy (CBT) is the most effective treatment for binge eating disorder (BED) but is limited by modest efficacy and low reach of in-person delivery. Combining mindfulness training with CBT could enhance efficacy by targeting emotion dysregulation, a key factor in BED that CBT does not adequately target. Digital delivery can enhance the reach of treatment. Accordingly, we developed CBT-based Mindful Courage, a 16-session digital intervention combining CBT and mindfulness training for BED. OBJECTIVE The aim of this study is to conduct a pilot randomized controlled trial to evaluate the feasibility (intervention and assessment completion) and acceptability (usability, overall satisfaction, engagement, visual appeal of content, understandability of program content, desire to continue the program, perceived skill acquisition, perceived confidence in implementing skills, and perceived helpfulness) of CBT-based Mindful Courage. We will also evaluate changes in outcomes (binge eating frequency, eating disorder symptoms, clinical impairment, and depression symptoms) and mechanisms (emotion dysregulation, dietary overrestriction, and trait mindfulness). METHODS This is a parallel-group, single-blinded, randomized controlled trial with a 1:1 allocation ratio. It will be conducted from November 2025 to November 2026, with study assessments at baseline, midtreatment, end-of-treatment, and 2-month follow-up. We will recruit a volunteer sample of adults with BED (N=40) aged 18 to 75 years via online advertisements. Exclusion criteria include a BMI <18.5, current anorexia or bulimia nervosa, and current treatment for BED or weight loss. Participants will be randomly allocated to an active control that includes coached self-monitoring (self-monitoring of food intake in Recovery Record and coaching calls by a research assistant) or to CBT-based Mindful Courage+coached self-monitoring. Both conditions will have a duration of 18 weeks. All study sessions will take place over Zoom. RESULTS The study was funded in April 2023. Data collection began in November 2025, and we anticipate recruitment to be completed by November 2026. Results are expected to be analyzed by May 2027 and published by May 2028. CONCLUSIONS This will be an important first step in creating a scalable and efficacious treatment for BED. CLINICALTRIAL ClinicalTrials.gov NCT07212673; https://clinicaltrials.gov/study/NCT07212673 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/91761
- 1 April 2025
- Published by Wiley in International Journal of Eating Disorders
- Vol. 58 (7) , 1392-1398
Patterns of Symptom Change in Behaviors and Cognitions During 10‐Session Cognitive Behavioral Therapy (CBT‐T) for Non‐Underweight Eating Disorders
Objective: Little is known about the timing of behavioral versus cognitive change in 10‐session cognitive‐behavioral therapy for non‐underweight eating disorders (CBT‐T). We aimed to: (a) evaluate the magnitude of behavioral and cognitive symptom reduction across treatment; and (b) investigate the relation between early behavioral change and subsequent cognitive change. We hypothesized: (a) large and significant reductions in behavioral and cognitive symptoms from pre‐ to mid‐treatment and from pre‐ to post‐treatment; and (b) that early behavioral change would predict subsequent cognitive change over the course of treatment.Method: Patients (N = 63) were offered CBT‐T and completed the Eating Disorder‐15 on a weekly basis. We used intent‐to‐treat analyses. For Aim 1, we conducted a series of fixed‐effect multilevel models for each outcome variable, accounting for repeated measures (pre‐, mid‐, and post‐treatment) within individuals. For Aim 2, we conducted a linear regression using early behavioral change as the predictor and subsequent cognitive change as the outcome.Results: We observed large and significant reductions in most behavioral and all cognitive symptoms pre‐ to mid‐treatment and pre‐ to post‐treatment. Early changes in behavioral symptoms did not significantly predict subsequent cognitive changes.Discussion: Behavioral improvements occurred rapidly and were sustained throughout treatment, whereas cognitive changes followed a more gradual trajectory. The absence of a significant predictive relationship between early behavioral change and subsequent cognitive change suggests that these domains may improve independently. Future research should investigate the mechanisms linking behavioral and cognitive changes.
- 1 April 2025
- Published by Wiley in International Journal of Eating Disorders
- Vol. 58 (7) , 1392-1398
Patterns of Symptom Change in Behaviors and Cognitions During 10‐Session Cognitive Behavioral Therapy (CBT‐T) for Non‐Underweight Eating Disorders
Objective: Little is known about the timing of behavioral versus cognitive change in 10‐session cognitive‐behavioral therapy for non‐underweight eating disorders (CBT‐T). We aimed to: (a) evaluate the magnitude of behavioral and cognitive symptom reduction across treatment; and (b) investigate the relation between early behavioral change and subsequent cognitive change. We hypothesized: (a) large and significant reductions in behavioral and cognitive symptoms from pre‐ to mid‐treatment and from pre‐ to post‐treatment; and (b) that early behavioral change would predict subsequent cognitive change over the course of treatment.Method: Patients (N = 63) were offered CBT‐T and completed the Eating Disorder‐15 on a weekly basis. We used intent‐to‐treat analyses. For Aim 1, we conducted a series of fixed‐effect multilevel models for each outcome variable, accounting for repeated measures (pre‐, mid‐, and post‐treatment) within individuals. For Aim 2, we conducted a linear regression using early behavioral change as the predictor and subsequent cognitive change as the outcome.Results: We observed large and significant reductions in most behavioral and all cognitive symptoms pre‐ to mid‐treatment and pre‐ to post‐treatment. Early changes in behavioral symptoms did not significantly predict subsequent cognitive changes.Discussion: Behavioral improvements occurred rapidly and were sustained throughout treatment, whereas cognitive changes followed a more gradual trajectory. The absence of a significant predictive relationship between early behavioral change and subsequent cognitive change suggests that these domains may improve independently. Future research should investigate the mechanisms linking behavioral and cognitive changes.
- 17 January 2025
- Published by Wiley in International Journal of Eating Disorders
- Vol. 58 (4) , 703-713
Differences in Perceived Versus Actual Sensory Perception in Avoidant/Restrictive Food Intake Disorder
Background: Individuals with avoidant/restrictive food intake disorder (ARFID) self‐report heightened sensitivity to taste and smell, but neither phenomenon has been systematically explored in the laboratory. We hypothesized that, compared to healthy controls (HC, n = 34), children, adolescents, and adults with full/subthreshold ARFID (n = 100; ages 9 to 23 years) would self‐report heightened response to taste/smell stimuli and exhibit stronger bitter taste perception and heightened smell perception in performance‐based tasks, and these differences would be especially prominent in those with the ARFID‐sensory sensitivity presentation.Method: We measured self‐reported sensitivity to taste/smell with the adolescent/adult sensory profile (AASP). We measured performance‐based bitter taste perception with the regional taste intensity test (RTIT) and 6‐N‐propylthiouracil (PROP) test, and olfactory performance with the Sniffin' Sticks test (including the odor threshold, odor detection, and odor identification subscales).Results: As expected, the ARFID group self‐reported heightened response to taste/smell on the AASP, compared to HC, with an especially large effect size in the subset with the ARFID‐sensory sensitivity presentation. Contrary to hypotheses, on performance‐based measures, neither the ARFID group—nor the ARFID‐sensory sensitivity group specifically—demonstrated heightened sensitivity to bitter taste on the RTIT or PROP tests, nor heightened smell perception on the Sniffin' Sticks test.Conclusion: These first laboratory findings in a clinically diagnosed sample of individuals with full/subthreshold ARFID highlight the discrepancy between perceived versus actual sensitivity to taste/smell stimuli. Future research should explore whether this discrepancy can be replicated and therapeutically leveraged to facilitate successful food exposures.
- 17 January 2025
- Published by Wiley in International Journal of Eating Disorders
- Vol. 58 (4) , 703-713
Differences in Perceived Versus Actual Sensory Perception in Avoidant/Restrictive Food Intake Disorder
Background: Individuals with avoidant/restrictive food intake disorder (ARFID) self‐report heightened sensitivity to taste and smell, but neither phenomenon has been systematically explored in the laboratory. We hypothesized that, compared to healthy controls (HC, n = 34), children, adolescents, and adults with full/subthreshold ARFID (n = 100; ages 9 to 23 years) would self‐report heightened response to taste/smell stimuli and exhibit stronger bitter taste perception and heightened smell perception in performance‐based tasks, and these differences would be especially prominent in those with the ARFID‐sensory sensitivity presentation.Method: We measured self‐reported sensitivity to taste/smell with the adolescent/adult sensory profile (AASP). We measured performance‐based bitter taste perception with the regional taste intensity test (RTIT) and 6‐N‐propylthiouracil (PROP) test, and olfactory performance with the Sniffin' Sticks test (including the odor threshold, odor detection, and odor identification subscales).Results: As expected, the ARFID group self‐reported heightened response to taste/smell on the AASP, compared to HC, with an especially large effect size in the subset with the ARFID‐sensory sensitivity presentation. Contrary to hypotheses, on performance‐based measures, neither the ARFID group—nor the ARFID‐sensory sensitivity group specifically—demonstrated heightened sensitivity to bitter taste on the RTIT or PROP tests, nor heightened smell perception on the Sniffin' Sticks test.Conclusion: These first laboratory findings in a clinically diagnosed sample of individuals with full/subthreshold ARFID highlight the discrepancy between perceived versus actual sensitivity to taste/smell stimuli. Future research should explore whether this discrepancy can be replicated and therapeutically leveraged to facilitate successful food exposures.
- 16 December 2024
- Published by Wiley in International Journal of Eating Disorders
- Vol. 58 (3) , 647-653
Predictors of Outcome in Cognitive‐Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder
Objective: Cognitive‐behavioral therapy for avoidant/restrictive food intake disorder (ARFID; CBT‐AR) shows promise in improving clinical outcomes in children/adolescents and adults. We aimed to identify predictors of outcomes in CBT‐AR. We hypothesized that younger age, non‐underweight status, and presence of the fear of aversive consequences profile of ARFID would predict greater likelihood of remission post–treatment, and that presence of the lack of interest in eating/food and sensory sensitivity profiles would predict greater likelihood of persistence post‐treatment. We included sex as an exploratory predictor.Method: Individuals (N = 94, ages 10–55 years) were offered 20–30 outpatient sessions of CBT‐AR. We collected clinical and demographic data at pre‐treatment, and remission status at post‐treatment.Results: Consistent with our hypothesis, presence (versus absence) of the fear profile predicted an almost three‐fold increased likelihood of remission. Presence of the sensory profile, lack of interest profile, age, weight status, and sex were not predictors of ARFID outcome.Discussion: The fear of aversive consequences profile of ARFID may be more amenable to treatment with CBT‐AR. This is the first study to identify predictors of treatment outcome following CBT‐AR. Randomized controlled trials are needed to confirm these findings and examine moderators.
- 16 December 2024
- Published by Wiley in International Journal of Eating Disorders
- Vol. 58 (3) , 647-653
Predictors of Outcome in Cognitive‐Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder
Objective: Cognitive‐behavioral therapy for avoidant/restrictive food intake disorder (ARFID; CBT‐AR) shows promise in improving clinical outcomes in children/adolescents and adults. We aimed to identify predictors of outcomes in CBT‐AR. We hypothesized that younger age, non‐underweight status, and presence of the fear of aversive consequences profile of ARFID would predict greater likelihood of remission post–treatment, and that presence of the lack of interest in eating/food and sensory sensitivity profiles would predict greater likelihood of persistence post‐treatment. We included sex as an exploratory predictor.Method: Individuals (N = 94, ages 10–55 years) were offered 20–30 outpatient sessions of CBT‐AR. We collected clinical and demographic data at pre‐treatment, and remission status at post‐treatment.Results: Consistent with our hypothesis, presence (versus absence) of the fear profile predicted an almost three‐fold increased likelihood of remission. Presence of the sensory profile, lack of interest profile, age, weight status, and sex were not predictors of ARFID outcome.Discussion: The fear of aversive consequences profile of ARFID may be more amenable to treatment with CBT‐AR. This is the first study to identify predictors of treatment outcome following CBT‐AR. Randomized controlled trials are needed to confirm these findings and examine moderators.
- 1 September 2024
- Published by Wiley in International Journal of Eating Disorders
- Vol. 57 (11) , 2156-2166
Difficulties in Emotion Regulation in Avoidant/Restrictive Food Intake Disorder
Objective: Despite substantial research indicating difficulties with emotion regulation across eating disorder presentations, emotion regulation has yet to be studied in adults with avoidant/restrictive food intake disorder (ARFID). We hypothesized that (1) those with ARFID would report greater overall emotion regulation difficulties than nonclinical participants, and (2) those with ARFID would not differ from those with other eating disorders on the level of emotion regulation difficulty.Methods: One hundred and thirty‐seven adults (age 18–30) from an outpatient clinic with ARFID (n = 27), with other primarily restrictive eating disorders (e.g., anorexia nervosa; n = 34), and with binge/purge eating disorders (e.g., bulimia nervosa; n = 51), as well as nonclinical participants (n = 25) recruited via Amazon Mechanical Turk (MTurk) completed the Difficulties in Emotion Regulation Scale (DERS). We compared DERS scores across groups.Results: In line with expectations, patients with ARFID scored significantly higher than nonclinical participants on the DERS Total (p = 0.01) with a large effect size (d = 0.87). Also as hypothesized, those with ARFID did not differ from those with other primarily restrictive (p = 0.99) or binge/purge disorders (p = 0.29) on DERS Total.Discussion: Adults with ARFID appear to exhibit emotion regulation difficulties which are greater than nonclinical participants, and commensurate with other eating disorders. These findings highlight the possibility of emotion regulation difficulties as a maintenance mechanism for ARFID.
- 1 September 2024
- Published by Wiley in International Journal of Eating Disorders
- Vol. 57 (11) , 2156-2166
Difficulties in Emotion Regulation in Avoidant/Restrictive Food Intake Disorder
Objective: Despite substantial research indicating difficulties with emotion regulation across eating disorder presentations, emotion regulation has yet to be studied in adults with avoidant/restrictive food intake disorder (ARFID). We hypothesized that (1) those with ARFID would report greater overall emotion regulation difficulties than nonclinical participants, and (2) those with ARFID would not differ from those with other eating disorders on the level of emotion regulation difficulty.Methods: One hundred and thirty‐seven adults (age 18–30) from an outpatient clinic with ARFID (n = 27), with other primarily restrictive eating disorders (e.g., anorexia nervosa; n = 34), and with binge/purge eating disorders (e.g., bulimia nervosa; n = 51), as well as nonclinical participants (n = 25) recruited via Amazon Mechanical Turk (MTurk) completed the Difficulties in Emotion Regulation Scale (DERS). We compared DERS scores across groups.Results: In line with expectations, patients with ARFID scored significantly higher than nonclinical participants on the DERS Total (p = 0.01) with a large effect size (d = 0.87). Also as hypothesized, those with ARFID did not differ from those with other primarily restrictive (p = 0.99) or binge/purge disorders (p = 0.29) on DERS Total.Discussion: Adults with ARFID appear to exhibit emotion regulation difficulties which are greater than nonclinical participants, and commensurate with other eating disorders. These findings highlight the possibility of emotion regulation difficulties as a maintenance mechanism for ARFID.
- 27 May 2024
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 54 (11) , 2956-2966
Latent profile analysis reveals overlapping ARFID and shape/weight motivations for restriction in eating disorders
Background: DSM-5 differentiates avoidant/restrictive food intake disorder (ARFID) from other eating disorders (EDs) by a lack of overvaluation of body weight/shape driving restrictive eating. However, clinical observations and research demonstrate ARFID and shape/weight motivations sometimes co-occur. To inform classification, we: (1) derived profiles underlying restriction motivation and examined their validity and (2) described diagnostic characterizations of individuals in each profile to explore whether findings support current diagnostic schemes. We expected, consistent with DSM-5, that profiles would comprise individuals endorsing solely ARFID or restraint (i.e. trying to eat less to control shape/weight) motivations.Methods: We applied latent profile analysis to 202 treatment-seeking individuals (ages 10–79 years [M = 26, s.d. = 14], 76% female) with ARFID or a non-ARFID ED, using the Nine-Item ARFID Screen (Picky, Appetite, and Fear subscales) and the Eating Disorder Examination-Questionnaire Restraint subscale as indicators.Results: A 5-profile solution emerged: Restraint/ARFID-Mixed (n = 24; 8% [n = 2] with ARFID diagnosis); ARFID-2 (with Picky/Appetite; n = 56; 82% ARFID); ARFID-3 (with Picky/Appetite/Fear; n = 40; 68% ARFID); Restraint (n = 45; 11% ARFID); and Non-Endorsers (n = 37; 2% ARFID). Two profiles comprised individuals endorsing solely ARFID motivations (ARFID-2, ARFID-3) and one comprising solely restraint motivations (Restraint), consistent with DSM-5. However, Restraint/ARFID-Mixed (92% non-ARFID ED diagnoses, comprising 18% of those with non-ARFID ED diagnoses in the full sample) endorsed ARFID and restraint motivations.Conclusions: The heterogeneous profiles identified suggest ARFID and restraint motivations for dietary restriction may overlap somewhat and that individuals with non-ARFID EDs can also endorse high ARFID symptoms. Future research should clarify diagnostic boundaries between ARFID and non-ARFID EDs.
- 27 May 2024
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 54 (11) , 2956-2966
Latent profile analysis reveals overlapping ARFID and shape/weight motivations for restriction in eating disorders
Background: DSM-5 differentiates avoidant/restrictive food intake disorder (ARFID) from other eating disorders (EDs) by a lack of overvaluation of body weight/shape driving restrictive eating. However, clinical observations and research demonstrate ARFID and shape/weight motivations sometimes co-occur. To inform classification, we: (1) derived profiles underlying restriction motivation and examined their validity and (2) described diagnostic characterizations of individuals in each profile to explore whether findings support current diagnostic schemes. We expected, consistent with DSM-5, that profiles would comprise individuals endorsing solely ARFID or restraint (i.e. trying to eat less to control shape/weight) motivations.Methods: We applied latent profile analysis to 202 treatment-seeking individuals (ages 10–79 years [M = 26, s.d. = 14], 76% female) with ARFID or a non-ARFID ED, using the Nine-Item ARFID Screen (Picky, Appetite, and Fear subscales) and the Eating Disorder Examination-Questionnaire Restraint subscale as indicators.Results: A 5-profile solution emerged: Restraint/ARFID-Mixed (n = 24; 8% [n = 2] with ARFID diagnosis); ARFID-2 (with Picky/Appetite; n = 56; 82% ARFID); ARFID-3 (with Picky/Appetite/Fear; n = 40; 68% ARFID); Restraint (n = 45; 11% ARFID); and Non-Endorsers (n = 37; 2% ARFID). Two profiles comprised individuals endorsing solely ARFID motivations (ARFID-2, ARFID-3) and one comprising solely restraint motivations (Restraint), consistent with DSM-5. However, Restraint/ARFID-Mixed (92% non-ARFID ED diagnoses, comprising 18% of those with non-ARFID ED diagnoses in the full sample) endorsed ARFID and restraint motivations.Conclusions: The heterogeneous profiles identified suggest ARFID and restraint motivations for dietary restriction may overlap somewhat and that individuals with non-ARFID EDs can also endorse high ARFID symptoms. Future research should clarify diagnostic boundaries between ARFID and non-ARFID EDs.